or Try an Advanced Search...

    Advanced Prostate Cancer Stocks List

    Symbol Grade Name % Change
    ABBV B AbbVie Inc. -0.67
    EPIX F ESSA Pharma Inc. -2.66
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Pharmaceutical Adalimumab Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Cancer Chronic Idiopathic Constipation Combination Drugs Constipation Crohn's Disease Depressive Disorder Endometriosis Eye Care Products Genotype Hematological Malignancies Hepatitis C Hepatitis C Virus Histopathology Hypothyroidism

    Related ETFs - A few ETFs which own one or more of the above listed Advanced Prostate Cancer stocks.

    Symbol Grade Name Weight
    MEDI C Harbor Health Care ETF 10.38
    BOTZ C Global X Robotics & Artificial Intelligence Thematic ETF 10.01
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    GRID D First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund 8.31
    FDL A First Trust Morningstar ETF 8.12
    View all Advanced Prostate Cancer ETFs...
    Compare ETFs
    Compare BOTZ to HDLB Compare HDLB to GRID Compare MEDI to BOTZ

        Advanced Prostate Cancer Stocks Recent News

        Date Stock Title
        Jul 1 ABBV 2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
        Jul 1 ABBV AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
        Jul 1 ABBV AbbVie names Robert A. Michael to CEO role
        Jul 1 ABBV Robert A. Michael Assumes Role as AbbVie Chief Executive Officer
        Jul 1 ABBV 3 Magnificent Stocks Retirees Can Buy and Hold Forever
        Jul 1 ABBV 10 clinical trials to watch in the second half of 2024
        Jun 29 ABBV How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
        Jun 28 ABBV How Medicare drug price negotiations could hit pharma stocks
        Jun 28 ABBV Coherus offloads Humira biosimilar Yusimry for $40m
        Jun 28 ABBV AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
        Jun 28 ABBV AbbVie, Genmab blood cancer therapy endorsed in EU
        Jun 28 ABBV Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
        Jun 28 ABBV AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
        Jun 28 ABBV AbbVie completes acquisition of Celsius Therapeutics for $250m
        Jun 28 ABBV AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
        Jun 27 ABBV FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
        Jun 27 ABBV Merck's (MRK) Lung Cancer Candidate Faces FDA Rejection
        Jun 27 ABBV AbbVie buys bowel disease drug developer Celsius for $250M
        Jun 27 ABBV AbbVie Acquires Celsius Therapeutics
        Jun 27 ABBV Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?
        Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Pharmaceutical Adalimumab Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Cancer Chronic Idiopathic Constipation Combination Drugs Constipation Crohn's Disease Depressive Disorder Endometriosis Eye Care Products Genotype Hematological Malignancies Hepatitis C Hepatitis C Virus Histopathology Hypothyroidism
        Advanced Prostate Cancer

        Advanced prostate cancer is a form of prostate cancer that has spread beyond the prostate gland to other parts of the body, such as the bones, lymph nodes, or other organs. It is also known as metastatic prostate cancer. Advanced prostate cancer is typically more difficult to treat than early-stage prostate cancer, and the prognosis is generally poorer. Treatment options may include hormone therapy, chemotherapy, radiation therapy, and/or surgery.

        Browse All Tags